Approaches Beyond Classic CAR T-Cells – Module 2

Program Overview

Navigating the Frontier of Hematologic Malignancy Therapies (2 of 5 Modules)

This activity provides an overview of novel approaches to T-cell immunotherapy, particularly the development of “off-the-shelf” T-cell therapies in the management of lymphomas and other hematologic malignancies.

Credit Expired

Target Audience

Hematologists, oncologists, and other healthcare professionals involved in the diagnosis and treatment of patients with blood cancers.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Identify potential T-cell immunotherapeutic strategies for the treatment of lymphomas and other hematologic malignancies

Activity Faculty

Helen E. Heslop, MD, DSc (Hon) (Chair)

Professor, Departments of Medicine and Pediatrics
Director, Center for Cell and Gene Therapy
Dan L. Duncan Chair
Interim Director, Dan L. Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, TX

Featured RMEI CE Activities – Earn CE Credit(s)

Approaches Beyond Classic CAR T-Cells – Module 2

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Helen E. Heslop, MD, DSc (Hon) (Chair)

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care: A Care Team Forum®

Refining Management of CMV After Transplant: Exploiting Recent Advances to Alleviate Patient Burden

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

Subscribe